HMGB1 and myasthenia gravis: There was no statistically significant difference in age (p = 0.087), sex (p = 0.218) or serum concentrations of the indicated molecules when we compared MG+ (n = 10) with MG− (n = 29) patients with TETs: sRAGE [pg/ml] 300.7±61.4 vs. 224.5±37.3, p = 0.359; esRAGE [pg/ml] 268.1±26.3 vs. 380.5±47.5, p = 0.190; HMGB1 [ng/ml] 1.9±0.5 vs. 2.0±0.4, p = 0.889.